Patients’ perspective in the context of proton beam therapy: summary of a Nordic workshop

References

• Doyen J, Falk AT, Floquet V, et al. Proton beams in cancer treatments: clinical outcomes and dosimetric comparisons with photon therapy. Cancer Treat Rev. 2016;43:104–112.
   PubMed Web of Science ®Google Scholar
• Maquilan G, Grover S, Alonso-Basanta M, et al. Acute toxicity profile of patients with low-grade gliomas and meningiomas receiving proton therapy. Am J Clin Oncol. 2014;37(5):438–443.
   PubMed Web of Science ®Google Scholar
• McDonald MW, Liu Y, Moore MG, et al. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy. Radiat Oncol. 2016;11:32
   PubMed Web of Science ®Google Scholar
• Nguyen QN, Ly NB, Komaki R, et al. Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer. Radiother Oncol. 2015;115(3):367–372.
   PubMed Web of Science ®Google Scholar
• Wilson RR. Radiological use of fast protons. Radiology. 1946;47(5):487–491.
   PubMed Web of Science ®Google Scholar
• Lievens Y, Nagels K. Economic data for particle therapy: dealing with different needs in a heterogeneous landscape. Radiother Oncol. 2018;128(1):19–25.
   PubMed Web of Science ®Google Scholar
• Peeters A, Grutters JP, Pijls-Johannesma M, et al. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons. Radiother Oncol. 2010;95(1):45–53.
   PubMed Web of Science ®Google Scholar
• Coulter A. Engaging patients in healthcare Maidenhead. McGraw-Hill: Open University Press; 2011.
   Google Scholar
• Carman KL, Dardess P, Maurer M, et al. Patient and family engagement: a framework for understanding the elements and developing interventions and policies. Health Aff (Millwood)). 2013;32(2):223–231.
   PubMed Web of Science ®Google Scholar
• Pizzo E, Doyle C, Matthews R, et al. Patient and public involvement: how much do we spend and what are the benefits? Health Expect. 2015;18(6):1918–1926.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice G. Clinical practice guidelines we can trust. Washington (DC): National Academies Press (US); 2011.
   Google Scholar
• Qaseem A, Forland F, Macbeth F, et al. Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med. 2012;156(7):525–531.
   PubMed Web of Science ®Google Scholar
• National Cancer Research Institute, Clinical Translational Radiotherapy Research Working Group. Proton beam therapy - the challenges of delivering high-quality evidence of clinical benefit. Clin Oncol (R Coll Radiol). 2018;30:280–284.
   PubMed Web of Science ®Google Scholar
• SFS. SFS 2014:821. Stockholm: Socialstyrelsen [The National Board of Health and Welfare]; 2014.
   Google Scholar
• The National Board of Health and Welfare. Statens offentliga utredningar. En nationell stategi för framtiden. Stockholm: Socialdepartementet; 2009.
   Google Scholar
• Danskepatienter. The Danish knowledge center for user involvemnet in health care Köpenhamn: Danske patienter; 2011 [cited 2020 March 20]. Available from: https://www.danskepatienter.dk/about-danish-patients.
   Google Scholar
• Region-Midtjylland. Patientens og pårørandes indragelse som partnere, regional retningslinje Aarhus: Region Midtjylland; 2017 [cited 2020 March 20]. Available from: https://e-dok.rm.dk/edok/Admin/GUI.nsf/Desktop.html?open&openlink=http://e-dok.rm.dk/edok/enduser/portal.nsf/Main.html?open&unid=XAF2A901F96D830C0C125750F0052893C&level=AAUHPT&dbpath=/edok/editor/RM.nsf/&windowwidth=1100&windowheight=600&windowtitle=S%F8g
   Google Scholar
• Patrick DL, Burke LB, Powers JH, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10(2):S125–S137.
   PubMedGoogle Scholar
• Basch E. Beyond the FDA PRO guidance: steps toward integrating meaningful patient-reported outcomes into regulatory trials and US drug labels. Value Health. 2012;15(3):401–403.
   PubMed Web of Science ®Google Scholar
• Wallström S, Ekman I. Person-centred care in clinical assessment. Eur J Cardiovasc Nurs. 2018;17(7):576–579.
   PubMed Web of Science ®Google Scholar
• Langegard U, Ahlberg K, Fransson P, et al. Evaluation of quality of care in relation to health-related quality of life of patients diagnosed with brain tumor: a novel clinic for proton beam therapy. Support Care Cancer. 2019;27(7):2679–2691.. Nov 27.
   PubMed Web of Science ®Google Scholar
• Langegard U, Ahlberg K, Bjork-Eriksson T, et al. The art of living with symptoms: a qualitative study among patients with primary brain tumors receiving proton beam therapy. Cancer Nurs. 2019;43(2):E79–E86.
   Web of Science ®Google Scholar
• Langegard U, Johansson B, Bjork-Eriksson T, et al. Symptom clusters in patients with brain tumors undergoing proton beam therapy. Oncol Nurs Forum. 2019;46(3):349–363.
   PubMed Web of Science ®Google Scholar
• Möllerberg M-L, Langegård U, Johansson B, et al. Managing an altered social context patients experiences of staying away from home while undergoing proton beam therapy. Nursing Open. 2020. DOI:10.1002/nop2.490
   PubMed Web of Science ®Google Scholar
• Verma V, Simone CB, 2nd, Mishra MV. Quality of life and patient-reported outcomes following proton radiation therapy: a systematic review. J Natl Cancer Inst. 2018;110(4):341–353.
   Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370.
   PubMed Web of Science ®Google Scholar
• Savard M-H, Savard J, Simard S, et al. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology. 2005;14(6):429–441.
   PubMed Web of Science ®Google Scholar
• Smets EM, Garssen B, Cull A, et al. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer. 1996;73(2):241–245.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376.
   PubMed Web of Science ®Google Scholar
• Osoba D, Aaronson NK, Muller M, et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res. 1996;5(1):139–150.
   PubMed Web of Science ®Google Scholar
• Bortfeld TR, Loeffler JS. Three ways to make proton therapy affordable. Nature. 2017;549(7673):451–453.
   PubMed Web of Science ®Google Scholar
• Purnell TS, Calhoun EA, Golden SH, et al. Achieving health equity: closing the gaps in health care disparities, interventions, And Research. Health Aff (Millwood)). 2016;35(8):1410–1415.
   PubMed Web of Science ®Google Scholar
• Westman B, Kirkpatrick L, Ebrahim F, et al. Patient-reported experiences on supportive care strategies following the introduction of the first Swedish national cancer strategy and in accordance with the new patient act. Acta Oncol. 2018;57(3):382–392.
   PubMed Web of Science ®Google Scholar
• Sharkey K, Savulescu J, Aranda S, et al. Clinician gate-keeping in clinical research is not ethically defensible: an analysis. J Med Ethics. 2010;36(6):363–366.
   PubMed Web of Science ®Google Scholar